|
1
|
Alter MJ: Epidemiology of hepatitis C
virus infection. World J Gastroenterol. 13:2436–2441. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Irshad M, Mankotia DS and Irshad K: An
insight into the diagnosis and pathogenesis of hepatitis C virus
infection. World J Gastroenterol. 19:7896–7909. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lauer GM and Walker BD: Hepatitis C virus
infection. N Engl J Med. 345:41–52. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pybus OG, Barnes E, Taggart R, Lemey P,
Markov PV, Rasachak B, Syhavong B, Phetsouvanah R, Sheridan I,
Humphreys IS, et al: Genetic history of hepatitis C virus in East
Asia. J Virol. 83:1071–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xia GLLC, Cao HL, Bi SL, Zhan MY, Su CA,
Nan JH and Qi XQ: Prevalence of hepatitis B and C virus infections
in the general Chinese population. Results from a nationwide
cross-sectional seroepidemiologic study of hepatitis A, B, C, D and
E virus infections in China. Int Hepatol Commun. 5:62–73. 1996.
View Article : Google Scholar
|
|
6
|
Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto
M and Omata M: Detection of hepatitis C virus RNA in acute non-A,
non-B hepatitis as an early diagnostic tool. Biochem Biophys Res
Commun. 192:800–807. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuki N, Hayashi N, Ohkawa K, Hagiwara H,
Oshita M, Katayama K, Sasaki Y, Kasahara A, Fusamoto H and Kamada
T: The significance of immunoglobulin M antibody response to
hepatitis C virus core protein in patients with chronic hepatitis
C. Hepatology. 22:402–406. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
TCLDA: IDaPDB, . Prevention and treatment
of hepatitis C. Chin J Hepatol. 12:194–198. 2004.
|
|
9
|
Ding JYX and Zhang HM: Analysis on testing
of elderly patients with hepatitis C. Lab Med Clin. 17:1474–1475.
2009.
|
|
10
|
Wiese M, Fischer J, Lobermann M, Göbel U,
Grüngreiff K, Güthoff W, Kullig U, Richter F, Schiefke I, Tenckhoff
H, et al: East German HCV Study Group: Evaluation of liver disease
progression in the German hepatitis C virus (1b)-contaminated
anti-D cohort at 35 years after infection. Hepatology. 59:49–57.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zein NN: Clinical significance of
hepatitis C virus genotypes. Clin Microbiol Rev. 13:223–235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Messina JP, Humphreys I, Flaxman A, Brown
A, Cooke GS, Pybus OG and Barnes E: Global distribution and
prevalence of hepatitis C virus genotypes. Hepatology. 61:77–87.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Utama A, Budiarto BR, Monasari D, Octavia
TI, Chandra IS, Gani RA, Hasan I, Sanityoso A, Miskad US, Yusuf I,
et al: Hepatitis C virus genotype in blood donors and associated
liver disease in Indonesia. Intervirology. 51:410–416. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fried MW, Shiffman ML, Reddy KR, Smith C,
Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G,
Dhumeaux D, et al: Peginterferon alfa-2a plus ribavirin for chronic
hepatitis C virus infection. N Engl J Med. 347:975–982. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kieffer TL, Sarrazin C, Miller JS, Welker
MW, Forestier N, Reesink HW, Kwong AD and Zeuzem S: Telaprevir and
pegylated interferon-alpha-2a inhibit wild-type and resistant
genotype 1 hepatitis C virus replication in patients. Hepatology.
46:631–639. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kieffer TL, Kwong AD and Picchio GR: Viral
resistance to specifically targeted antiviral therapies for
hepatitis C (STAT-Cs). J Antimicrob Chemother. 65:202–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allain JP, Thomas I and Sauleda S: Nucleic
acid testing for emerging viral infections. Transfus Med.
12:275–283. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu GG, Wu SM, Zhou XQ, Zhang QB, Kang LY,
Zhou XM, Jiang Y, Qi X and Ren XJ: Clinical characteristics of 638
patients infected with hepatitis C virus by post blood transfusion,
in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi. 32:388–391.
2011.(In Chinese). PubMed/NCBI
|
|
19
|
Dabbouseh NM and Jensen DM: Future
therapies for chronic hepatitis C. Nat Rev Gastroenterol Hepatol.
10:268–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rerksuppaphol S, Hardikar W and Dore GJ:
Long-term outcome of vertically acquired and post-transfusion
hepatitis C infection in children. J Gastroenterol Hepatol.
19:1357–1362. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Poynard T, Bedossa P and Opolon P: Natural
history of liver fibrosis progression in patients with chronic
hepatitis C. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups.
Lancet. 349:825–832. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Conjeevaram HS, Fried MW, Jeffers LJ,
Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH,
Hoofnagle JH, Kleiner DE, et al: Peginterferon and ribavirin
treatment in African American and Caucasian American patients with
hepatitis C genotype 1. Gastroenterology. 131:470–477. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferenci P, Fried MW, Shiffman ML, Smith
CI, Marinos G, Goncales FL Jr, Häussinger D, Diago M, Carosi G,
Dhumeaux D, et al: Predicting sustained virological responses in
chronic hepatitis C patients treated with peginterferon alfa-2a (40
KD)/ribavirin. J Hepatol. 43:425–433. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jensen DM, Marcellin P, Freilich B,
Andreone P, Di Bisceglie A, Brandão-Mello CE, Reddy KR, Craxi A,
Martin AO, Teuber G, et al: Re-treatment of patients with chronic
hepatitis C who do not respond to peginterferon-alpha2b: A
randomized trial. Ann Intern Med. 150:528–540. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shiffman ML, Di Bisceglie AM, Lindsay KL,
Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky
HL, Lee WM, et al: Hepatitis C Antiviral Long-Term Treatment
Against Cirrhosis Trial Group.: Peginterferon alfa-2a and ribavirin
in patients with chronic hepatitis C who have failed prior
treatment. Gastroenterology. 126:1015–1023; discussion 1947. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alberti A, Benvegnù L, Boccato S, Ferrari
A and Sebastiani G: Natural history of initially mild chronic
hepatitis C. Dig Liver Dis. 36:646–654. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boccato S, Pistis R, Noventa F, Guido M,
Benvegnù L and Alberti A: Fibrosis progression in initially mild
chronic hepatitis C. J Viral Hepat. 13:297–302. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mohan P, Barton BA, Narkewicz MR,
Molleston JP, Gonzalez-Peralta RP, Rosenthal P, Murray KF, Haber B,
Schwarz KB and Goodman ZD: Evaluating progression of liver disease
from repeat liver biopsies in children with chronic hepatitis C: A
retrospective study. Hepatology. 58:1580–1586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Casiraghi MA, De Paschale M, Romanò L,
Biffi R, Assi A, Binelli G and Zanetti AR: Long-term outcome (35
years) of hepatitis C after acquisition of infection through mini
transfusions of blood given at birth. Hepatology. 39:90–96. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Minola E, Prati D, Suter F, Maggiolo F,
Caprioli F, Sonzogni A, Fraquelli M, Paggi S and Conte D: Age at
infection affects the long-term outcome of transfusion-associated
chronic hepatitis C. Blood. 99:4588–4591. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen SL and Morgan TR: The natural history
of hepatitis C virus (HCV) infection. Int J Med Sci. 3:47–52. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y,
Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH,
et al: Interrelationship of blood transfusion, non-A, non-B
hepatitis and hepatocellular carcinoma: Analysis by detection of
antibody to hepatitis C virus. Hepatology. 12:671–675. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tong MJ, el-Farra NS, Reikes AR and Co RL:
Clinical outcomes after transfusion-associated hepatitis C. N Engl
J Med. 332:1463–1466. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salhab M and Canelo R: An overview of
evidence-based management of hepatocellular carcinoma: A
meta-analysis. J Cancer Res Ther. 7:463–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reggiardo MV, Fay F, Tanno M,
Garcia-Camacho G, Bottaso O, Ferretti S, Godoy A, Guerrita C, Paez
M, Tanno F, et al: Natural history of hepatitis C virus infection
in a cohort of asymptomatic post-transfused subjects. Ann Hepatol.
11:658–666. 2012.PubMed/NCBI
|
|
36
|
Zavaglia C, Silini E, Mangia A, Airoldi A,
Piazzolla V, Vangeli M, Stigliano R, Foschi A, Mazzarelli C and
Tinelli C: Prognostic factors of hepatic decompensation and
hepatocellular carcinoma in patients with transfusion-acquired HCV
infection. Liver Int. 34:e308–e316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Akiyama T, Mizuta T, Kawazoe S, Eguchi Y,
Kawaguchi Y, Takahashi H, Ozaki I and Fujimoto K: Body mass index
is associated with age-at-onset of HCV-infected hepatocellular
carcinoma patients. World J Gastroenterol. 17:914–921. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Farinati F, Sergio A, Giacomin A, Di Nolfo
MA, Del Poggio P, Benvegnu L, Rapaccini G, Zoli M, Borzio F,
Giannini EG, et al: Italian Liver Cancer group: Is female sex a
significant favorable prognostic factor in hepatocellular
carcinoma? Eur J Gastroenterol Hepatol. 21:1212–1218. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shimizu I and Ito S: Protection of
estrogens against the progression of chronic liver disease. Hepatol
Res. 37:239–247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto
M and Omata M: Quantification of hepatitis C virus by competitive
reverse transcription-polymerase chain reaction: Increase of the
virus in advanced liver disease. Hepatology. 18:16–20. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mita E, Hayashi N, Kanazawa Y, Hagiwara H,
Ueda K, Kasahara A, Fusamoto H and Kamada T: Hepatitis C virus
genotype and RNA titer in the progression of type C chronic liver
disease. J Hepatol. 21:468–473. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ripoli M and Pazienza V: Impact of HCV
genetic differences on pathobiology of disease. Expert Rev Anti
Infect Ther. 9:747–759. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Silini E, Bono F, Cividini A, Cerino A,
Bruno S, Rossi S, Belloni G, Brugnetti B, Civardi E, Salvaneschi L,
et al: Differential distribution of hepatitis C virus genotypes in
patients with and without liver function abnormalities. Hepatology.
21:285–290. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kobayashi M, Tanaka E, Sodeyama T,
Urushihara A, Matsumoto A and Kiyosawa K: The natural course of
chronic hepatitis C: A comparison between patients with genotypes 1
and 2 hepatitis C viruses. Hepatology. 23:695–699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Silini E, Bottelli R, Asti M, Bruno S,
Candusso ME, Brambilla S, Bono F, Iamoni G, Tinelli C, Mondelli MU
and Ideo G: Hepatitis C virus genotypes and risk of hepatocellular
carcinoma in cirrhosis: A case-control study. Gastroenterology.
111:199–205. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Takada A, Tsutsumi M, Zhang SC, Okanoue T,
Matsushima T, Fujiyama S and Komatsu M: Relationship between
hepatocellular carcinoma and subtypes of hepatitis C virus: A
nationwide analysis. J Gastroenterol Hepatol. 11:166–169. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dusheiko G, Schmilovitz-Weiss H, Brown D,
McOmish F, Yap PL, Sherlock S, McIntyre N and Simmonds P: Hepatitis
C virus genotypes: An investigation of type-specific differences in
geographic origin and disease. Hepatology. 19:13–18. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yamada M, Kakumu S, Yoshioka K, Higashi Y,
Tanaka K, Ishikawa T and Takayanagi M: Hepatitis C virus genotypes
are not responsible for development of serious liver disease. Dig
Dis Sci. 39:234–239. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dong ZX, Zhou HJ, Wang JH, Xiang XG,
Zhuang Y, Guo SM, Gui HL, Zhao GD, Tang WL, Wang H and Xie Q:
Distribution of hepatitis C virus genotypes in Chinese patients
with chronic hepatitis C: Correlation with patients'
characteristics and clinical parameters. J Dig Dis. 13:564–570.
2012. View Article : Google Scholar : PubMed/NCBI
|
